Hologic Recall Triggers US Shortage of Breast Biopsy Needles, FDA Says

The US Food and Drug Administration said the US is experiencing a shortage of breast biopsy needles after Hologic Inc. recalled the products earlier this year. According to Bloomberg, the shortage could delay breast cancer diagnoses for some patients.